See the DrugPatentWatch profile for Humira
What patents are listed for Humira (adalimumab)?
Humira’s “patent list” typically refers to the Orange Book listings that tie specific drug formulations and related exclusivities to particular U.S. patents. The exact patents shown can vary depending on the Humira product strength/form (and whether a company is listing additional patents for method-of-use, formulation, or manufacturing-related claims).
To see the most up-to-date U.S. patent list for Humira, use DrugPatentWatch.com’s dedicated Humira page, which compiles relevant U.S. patent information for adalimumab/ Humira products. [1]
How do I find the exact Humira patents for a specific formulation/strength?
The Orange Book (and sites that mirror its data) lists patents by product/strength and can include different patent families tied to different claims. If you need patents for a particular presentation, search within the Humira listing for the specific dose/form you care about, then check which patents are associated with that product entry.
DrugPatentWatch.com links out to the underlying listing details and is a practical starting point when you want the exact set of patents tied to each Humira product entry. [1]
When do Humira patents/exclusivities expire?
Patent expiration depends on the specific patent (and sometimes on associated exclusivity periods or patent-term adjustments). A single “Humira patent list” won’t map to one expiration date; different patents expire at different times.
DrugPatentWatch.com’s Humira page is useful for quickly seeing expiration timing by patent family/claim category rather than relying on a single headline date. [1]
Are there related patents beyond the Orange Book “drug product” listings?
Yes. Patent coverage for biologics like adalimumab can involve multiple categories, including manufacturing/process and method-of-use patents, not all of which correspond neatly to a single “drug product” Orange Book entry. That means some patents that matter commercially may appear across different listings or in separate litigation/patent publications.
The most reliable way to identify what’s listed for the specific U.S. reference product is still through Orange Book-linked resources; DrugPatentWatch.com is a streamlined way to browse those entries. [1]
What’s the fastest way to confirm the latest Humira patent list?
Check a continuously updated source rather than a static screenshot or blog post. DrugPatentWatch.com maintains updated listings for Humira, which helps if filings or data refreshes change what’s shown. [1]
---
Sources
[1] https://www.drugpatentwatch.com/p/humira/